The Treatment

Unique fully ambulatory procedure that will transform haemorrhoid care globally.

Patented, fully mobile technology enabling highly convenient & safe treatment in a range of settings.

Evaluation of ongoing treatment quality and outcomes, assurance of efficacy and real world benefit.

 Increase the quality and range of services to your patients with a high degree of safety, assurance and profitability.

A portfolio and profit building option for high quality distributors and master distributors.

A non surgical haemorrhoid treatment

The eXroid treatment system

The eXroid brand of 16mA electrotherapy provides a revolutionary transformation of haemorrhoid treatment options to patients and providers.

Research studies show the treatment as the clear option of choice for patients due to its safety, simplicity, convenience (as a walk-in, walk-out treatment with no need for anaesthesia*), and assurance of minimal and often no pain during or after the procedure. Over 90% of patients report returning to normal duties on the same day as treatment.

*Clinicians and patients can opt for anaesthesia as an elective choice, but it is not required when administering the treatment, enabling it to be performed in acute, primary and even homecare settings.

With over 163,000 treatments globally, the 150 year old science of electrotherapy for the treatment of haemorrhoids is now revolutionising the safety and flexibility of clinical intervention through our patented and innovation award winning technology.

For practitioners the treatment is very simple and safe to perform, with instant visual benefit and symptom relief in almost all cases.

All practitioners are supported with regulatory compliant training which is an addition to their CPD.Our partners benefit from a simple go to market framework with clear revenue driven outcomes and plans as part of our account management partnership support.

Coded and insured with global insurers

Our technology is now widely coded and reimbursed by major health systems and insurers. It can be administered with or without anaesthesia depending on provider / practitioner and patient choice, enabling a range of service options from homecare, outpatients, day surgery or main theatre delivery to be administered. The procedure is covered by ICC, OPCS, ICD-10 and AMAM CPT codes for treatment and reimbursement.

Coded and insured with global insurers

Our technology is now widely coded and reimbursed by major health systems and insurers. It can be administered with or without anaesthesia depending on provider / practitioner and patient choice, enabling a range of service options from homecare, outpatients, day surgery or main theatre delivery to be administered. The procedure is covered by ICC, OPCS, ICD-10 and AMAM CPT codes for treatment and reimbursement.

Winner: King's Awards for Enterprise: Innovation 2023

His Majesty The King has approved the Prime Minister’s recommendation that eXroid Technology receive a King’s Award for Enterprise in the Innovation category this year.

This prestigious accolade has been awarded to eXroid for their work in developing a highly safe and effective, fully ambulatory treatment for haemorrhoid sufferers, meaning that they are no longer faced with a choice of treatment options that are known to be extremely painful and carry risks of complications, to become symptom free.

The treatment in action

The treatment itself is very simple and has been clinically researched for over 150 years, with advances in medical technology now making it a mainstream practice.

The device generates a small current of up to 16mAmp, which feels only slightly uncomfortable, though not painful, which stimulates a chemical reaction in the haemorrhoid, creating an excess of alkali which accumulates to seal off the feeding varicose blood vessel.

Partnering with eXroid

eXroid is now expanding globally as a result of it’s highly successful clinical treatment business in the UK. We are looking to engage with Medical Device distributors and clinical partners who share our values to bring this revolutionary treatment to markets across the globe.

If you are interested in working with eXroid, either as a distribution partner or clinician, get in touch with the team.